Assistant Professor of Medicine, SUNY Stony Brook
Internal Medicine
Dr. Stanley S. Ostrow, MD
Stanley Ostrow is an expert in the field of Internal Medicine. He attended State University of New York Downstate Medical Center College of Medicine. He over the years received 3 awards: "Newsday - Top Doctors on Long Island", "Top Doctors: New York Metro Area" and "CMS Meaningful Use Stage 1 Certification". Stanley Ostrow is a published doctor. He published 20 publications, including: 'Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.' Stanley Ostrow is registered with Medicare and accepts Medicare payments.
Publications
- Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies.
- Doxorubicin, cyclophosphamide, and whole body hyperthermia for Treatment of advanced soft tissue sarcoma.
- Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung Cancer.
- Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung Carcinoma.
- The management of nonseminomatous testicular Cancer: current therapy and future directions.
- A phase II trail of vindesine in patients with refractory small-cell Carcinoma of the lung.
- Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival.
- Causes of death in patients with non-Hodgkin's lymphoma.
- Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of Cancer.
- Leptomeningeal Carcinomatosis in small cell Carcinoma of the lung.
- High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
- Cyclophosphamide and dimethylsulfoxide in the Treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.
- Nodular lymphoma. Prolongation of survival by complete remission.
- Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.
- Peripheral neuropathy after cis-platinum (II) (DDP) therapy.
- High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast Cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
- Quantitative changes in cis-dichlorodiammineplatinum(II) speciation in excreted urine with time after iv infusion in man: methods of Analysis, preliminary studies, and...
- Meningeal Carcinomatosis from small cell Carcinoma of the lung. Consequence of improved survival.
- Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.
Schools
SUNY Downstate Medical Center College Of Medicine
Saint Vincent39s Hospital
Brooklyn Jewish Hosp Interfaith Med Ctr
National Cancer Institute Nih
Nci
SUNY Stonybrook
Procedures Preformed
- Biopsy
- Bone Marrow Aspiration
- Breast Cancer Treatment
- Cancer Counseling
- View All
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Oncology
- Internal Medicine
Accepted Insurances
Awards
- Newsday - Top Doctors on Long Island
- Top Doctors: New York Metro Area
- CMS Meaningful Use Stage 1 Certification
Education
-
Interfaith Medical Center
-
State University of New York Downstate Medical Center College of Medicine
Hospital
-
Stony Brook University Medical Center
Drug Facts
NPI NUMBER |
|
1457355018 |
NPPES Provider LastName |
|
OSTROW |
NPPES Provider FirstName |
|
STANLEY |
NPPES Provider ZIPCode |
|
117333456 |
NPPES Provider State |
|
NY |
Specialty Description |
|
Hematology/Oncology |
Total Claim Count |
|
2592.0 |
Distinct Opioid Count |
|
7.0 |
Opioid Claim Count |
|
256.0 |
Percent Opioid Claims |
|
9.88 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1457355018 |
Last Name Of The Provider |
OSTROW |
First Name Of The Provider |
STANLEY |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog